Trastuzumab Deruxtecan for Breast Cancer NEJM

trastuzumab  Trastuzumab exposure for a relatively short period does not seem to substantially affect the pregnancy outcome In contrast, a more prolonged For treating certain types of breast, stomach or esophagus cancers, and othersTrastuzumab is available as a biosimilar medication See our biosimilar pamphlet

For treating certain types of breast, stomach or esophagus cancers, and othersTrastuzumab is available as a biosimilar medication See our biosimilar pamphlet Trastuzumab belongs to class of monoclonal antibody It binds selectively to a protein called human epidermal growth factor receptor 2

Trastuzumab exerts an antitumour activity and is used in the treatment of HER2-positive breast cancer HER2 protein overexpression is observed in 20%-30% of Common side effects of pertuzumab and trastuzumab · Risk of infection · Bruising and bleeding · Anaemia · Effects on the heart